Authors:
Qiuyin Cai, Ben Zhang, Hyuna Sung, Siew-Kee Low, Sun-Seog Kweon, Wei Lu, Jiajun Shi, Jirong Long, Wanqing Wen, Ji-Yeob Choi, Dong-Young Noh, Chen-Yang Shen, Keitaro Matsuo, Soo-Hwang Teo, Mi Kyung Kim, Ui Soon Khoo, Motoki Iwasaki, Mikael Hartman, Atsushi Takahashi, Kyota Ashikawa, Koichi Matsuda, Min-Ho Shin, Min Ho Park, Ying Zheng, Yong-Bing Xiang, Bu-Tian Ji, Sue K Park, Pei-Ei Wu, Chia-Ni Hsiung, Hidemi Ito, Yoshio Kasuga, Peter Kang, Shivaani Mariapun, Sei Hyun Ahn, Han Sung Kang, Kelvin Y K Chan, Ellen P S Man, Hiroji Iwata, Shoichiro Tsugane, Hui Miao, Jiemin Liao, Yusuke Nakamura, Michiaki Kubo, DRIVE GAME-ON Consortium, Ryan J Delahanty, Yanfeng Zhang, Bingshan Li, Chun Li, Yu-Tang Gao, Xiao-Ou Shu, Daehee Kang, & Wei Zheng
Summary:
In a three-stage genome-wide association study among East Asian women including 22,780 cases and 24,181 controls, we identified 3 genetic loci newly associated with breast cancer risk, including rs4951011 at 1q32.1 (in intron 2 of the ZC3H11A gene; P = 8.82 × 10−9), rs10474352 at 5q14.3 (near the ARRDC3 gene; P = 1.67 × 10−9) and rs2290203 at 15q26.1 (in intron 14 of the PRC1 gene; P = 4.25 × 10−8). We replicated these associations in 16,003 cases and 41,335 controls of European ancestry (P = 0.030, 0.004 and 0.010, respectively). Data from the ENCODE Project suggest that variants rs4951011 and rs10474352 might be located in an enhancer region and transcription factor binding sites, respectively. This study provides additional insights into the genetics and biology of breast cancer.
Source:
Nature Genetics; 46, 886-890 (07/20/14)